Enhancing ribosomal translation of backbone-altering nonproteinogenic amino acids via YebC and YeeN
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Takayuki Katoh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan. Hauptthemen laut MEDLINE: Amino Acids, Ribosomes, Protein Biosynthesis, Bacterial Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JST, ACT-X, Japan, JSPS Grant-in-Aid for Scientific Research.
Abstract (Originalsprache)
Development of genetic code reprogramming methodologies has enabled the ribosomal incorporation of diverse backbone-altering nonproteinogenic amino acids (BAAs)—including d-α-amino acids, β-amino acids, and N-methyl-α-amino acids—into nascent peptides. However, their incorporation is far less efficient than that of canonical l-α-amino acids. We previously demonstrated that the ribosomal E-site-binding translation factors, EF-P and ABC-F proteins, can enhance BAA incorporation. These findings motivated us to investigate additional ribosome-binding factors that might further facilitate this process. Here, we focused on two putative A-site-binding factors, YebC and YeeN, to activate A-site BAA-tRNA and facilitate efficient incorporation. When testing 11 BAAs for consecutive incorporation, YebC and YeeN yielded average enhancements of 2.1- and 2.7-fold, respectively, with an increase of up to 6.6-fold in specific cases. Furthermore, combining YebC with EF-P and Uup (a representative ABC-F protein) produced an 8.0-fold increase in the incorporation of two consecutive N-methyl-l-leucine residues, demonstrating a clear synergistic benefit. We also found that YebC and YeeN promote ribosomal synthesis of drug-like macrocyclic peptides enriched with BAAs, such as d-serine, 1-aminocyclobutane-1-carboxylic acid, N-methyl-l-alanine, and β3-homomethionine. These results pave the way for the ribosomal synthesis of diverse macrocyclic peptide libraries and their application in mRNA display-based screening for novel bioactive compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
- Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, Imizu-shi, Toyama 939-0398, Japan.
ORCID-Profile: Takayuki Katoh, Hiraku Takada
Förderung
- Japan Society for the Promotion of Science
- JST, ACT-X, Japan
- JSPS Grant-in-Aid for Scientific Research
Zitieren
APA
Katoh, T., & Takada, H. (2026). Enhancing ribosomal translation of backbone-altering nonproteinogenic amino acids via YebC and YeeN. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag617
Vancouver
Katoh T, Takada H. Enhancing ribosomal translation of backbone-altering nonproteinogenic amino acids via YebC and YeeN. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag617
BibTeX
@article{Katoh2026,
author = {Katoh, Takayuki and Takada, Hiraku},
title = {Enhancing ribosomal translation of backbone-altering nonproteinogenic amino acids via YebC and YeeN},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag617}
}
EUVIMED